ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PRM Proteome Sciences Plc

2.65
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.65 2.30 3.00 - 0.00 13:55:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 5.03M -2.44M -0.0083 -3.19 7.82M
Proteome Sciences Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 2.65p. Over the last year, Proteome Sciences shares have traded in a share price range of 2.30p to 5.50p.

Proteome Sciences currently has 295,182,056 shares in issue. The market capitalisation of Proteome Sciences is £7.82 million. Proteome Sciences has a price to earnings ratio (PE ratio) of -3.19.

Proteome Sciences Share Discussion Threads

Showing 157676 to 157696 of 158000 messages
Chat Pages: Latest  6308  6307  6306  6305  6304  6303  6302  6301  6300  6299  6298  6297  Older
DateSubjectAuthorDiscuss
12/8/2024
10:22
LOL just beat me to it jeffian!
elpirata
12/8/2024
10:17
I note that it is so long since the "last tree standing" was felled that the "undergrowth" has started to spring up again!
jeffian
12/8/2024
09:46
Teh #59800
monte1
12/8/2024
09:46
Take it Dom.
monte1
12/8/2024
09:46
Many thanks goatherd. He will be made up.
dominiccummings
12/8/2024
09:26
There are some rather interesting things stirring in the undergrowth about stroke. But, of course, that has happened before fruitlessly.

Also similar, but deeper in the undergrowth, about Alzheimer's, which is, of course the real biggy.

I would suggest your friend resigns himself to hold for at least another year. And hopes things happen sooner.

goatherd
12/8/2024
08:21
wasjobber ?
monte1
12/8/2024
07:34
IR-TMT increases mass spec performance by 4 to 5 fold.
pools2
07/8/2024
15:22
#93001,
Well you can't be! 93000 posts (plus a few hundred thousand on other PRM threads) and after 25 years sitting around the all-time low. 'Knowledgeable' posters, my @rse.

jeffian
07/8/2024
15:21
And so he jolly well should be imco.
monte1
07/8/2024
15:17
You must be very proud!
goatherd
07/8/2024
15:02
thats just open ended gambling
elpirata
07/8/2024
13:53
Maybe. Maybe not.

My money is on there is something that will come good. Sometime.

goatherd
07/8/2024
13:32
Thanks pools
glennrcharles
07/8/2024
12:52
Never seen a company with as few rns news announcements, maybe the next one will be a whopper to make up for this and a 25 year wait
the bull
07/8/2024
12:45
All of the testing, 'proving effectiveness and efficacy' has been successfully completed.

The UKCA/CE registration is simply a completion of paperwork exercise.

pools2
07/8/2024
12:43
Re Stoke test. Does CE Registration include proving effectiveness and efficacy? I.e proving that there is a low probability of mis diagnosis. Or has that been done and we are just going through a formal procedure which takes as long as it takes.
glennrcharles
07/8/2024
11:49
What like,Steiner,CJP,Jeremy.None of them added sweet FA,despite creaming the company quite handsomely for years.Maybe there is nothing there to extract.??
peverill
07/8/2024
11:20
I believe we will find out in due course.
goatherd
07/8/2024
09:32
Mariola has taken nearly 1m in wages,for what exactly???
peverill
05/8/2024
18:37
I thought I would remind everyone, or perhaps simply those that have forgotten, what the stroke test does, and why it is so important.

There are two types of Stroke
Ischaemic which is caused by a clot of arteries feeding to, or in, the brain
Haemorrhagic which is when an artery or vein in the brain leaks.

Haemorrhagic are difficult to treat. However Ischaemic can be treated with a very high success rate (something near 90%) provided a "clot-buster" drug is administered within about 4 hours of the stroke.

The problm is that is a clot-buster drug is given to a haemorrhagic stroke victim it will cause them to bleed even more, and s probably kill them.

The test Randox has developed, using Proteome biomarkers, tells which type of stroke the patient has had (or, indeed, if they have had only a TIA, or even no stroke), and, crucially, how long ago.

Given that information a clot-buster can be administered and around 90% of stroke victims will be returned virtually to normal.

About 83% of all strokes (not counting TIAs) are ischaemic so a lot of lives will be saved. High quality lives as well.

The drug now being recommended by NICE is tenecteplase, whose price is $8,251.96 per dose. So a $100 diagnostic seems very cheap to me.

Much of the information in this post comes from

goatherd
Chat Pages: Latest  6308  6307  6306  6305  6304  6303  6302  6301  6300  6299  6298  6297  Older

Your Recent History

Delayed Upgrade Clock